Biologics

Embracing Biosimilars

July 13, 2021

I know some people who are brand loyal because they are hesitant to change. I, however, am not one of them. And I take that approach in prescribing biologics and biosimilars for my patients, too.

ICER Crosses the Center Line

July 9, 2021

The admonition to the Institute for Clinical and Economic Review’s Beacon Hill economists should be quite simple: “Stay in your lane.”

How Biologics Transformed Care for MS Patients

May 19, 2021

For 20 years there wasn’t a single medication I could prescribe to help my patients overcome multiple sclerosis, a disease that gradually robbed them of their strength, vision, coordination, and also memory and thinking abilities.